Evidence map›Paper›PMID 26548594›Full record

ArticleEpidemiology and infection2016

Epidemiological analysis of pneumococcal serotype 19A in healthy children following PCV7 vaccination.

A Tóthpál, K Laub, S Kardos, T Tirczka, A Kocsis, M VAN DER Linden, O Dobay

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The complexity of serotype replacement of pneumococci.Human vaccines & immunotherapeutics · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

A TóthpálInstitute of Medical Microbiology,Semmelweis University,Budapest,Hungary.ORCID 0000-0002-5204-9450
K LaubInstitute of Medical Microbiology,Semmelweis University,Budapest,Hungary.
S KardosInstitute of Medical Microbiology,Semmelweis University,Budapest,Hungary.
T TirczkaPneumococcal Reference Laboratory,National Center for Epidemiology,Budapest,Hungary.
A KocsisCellCall Ltd,Budapest,Hungary.
M VAN DER LindenGerman National Reference Center for Streptococci; Department of Medical Microbiology,University Hospital RWTH Aachen,Aachen,Germany.
O DobayInstitute of Medical Microbiology,Semmelweis University,Budapest,Hungary.ORCID 0000-0001-7094-2288
Semmelweis University · HUBudapest University of Economics and Business · HULaboratoire National de Référence · MARWTH Aachen University · DE

Funding

Wellcome Trust
6 · The paper itself

Abstract

After the introduction of conjugate vaccines, a strong rearrangement of pneumococcal serotypes was observed globally. Probably most concerning was the emergence of serotype 19A, which has not only high invasive disease potential, but also high antibiotic resistance. In the current study we focused on the increased prevalence of serotype 19A after the PCV vaccination rate became widely used in Hungary. A total of 2262 children aged 3-6 years were screened for pneumococcus carriage using nasal swabs. Children were divided into two groups according to the vaccination rates, low level (group 1) vs. high level (group 2). While the carriage rate did not change over time (average 32·9%), the serotype distribution differed greatly in the two groups. The prevalence of serotype 19A increased >eightfold. Almost all 19A isolates had high-level macrolide resistance and elevated penicillin minimum inhibitory concentrations. Genotyping methods revealed that these new 19A isolates are different from the previously frequent Hungary19A-6 PMEN clone. Both the carriage rate and the overall penicillin and macrolide resistance remained stable over time, but while several serotypes were represented in group 1, serotype 19A alone was clearly dominant in group 2.

Indexed as

Carrier StateChildChild, PreschoolFemaleHeptavalent Pneumococcal Conjugate VaccineHumansHungaryMalePneumococcal InfectionsSerogroupStreptococcus pneumoniaeVaccines, ConjugateHeptavalent Pneumococcal Conjugate VaccineVaccines, ConjugatePneumococcusresistanceserotypesvaccination

Identifiers

PMID26548594
PMCPMC9150583
OpenAlexW2195041459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.